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India has one of the largest injecting drug 
user (IDU) populations in the world, esti-
mated at 177,000 nationally and 17,000 in 
Delhi alone.1, 2 Injection practices such as 
needle sharing and drawing up drugs from 
a common container, and high-risk sexual 
behaviours such as having multiple partners 
and unprotected sex fuel the HIV epidemic 
among IDUs as well as their injecting and 
sex partners. 
Reducing sexual and injection risk be-
haviours is critical to controlling the HIV 
epidemic among IDUs and their sex part-
ners. Evidence indicates that HIV-positive 
IDUs reduce transmission behaviours upon 
learning their HIV status.3–7 Thus, HIV testing 
offers an entry point into targeted services 
for IDUs that may reduce risk behaviour. The 
Population Council, in collaboration with the 
Sahara Centre for Residential Care and Re-
habilitation (Sahara) and Arise—Enhancing 
HIV Prevention Programs for At-Risk Popula-
tions is implementing a project to avert HIV 
infections among IDUs and their sexual and 
injecting partners in Delhi by increasing the 
uptake of HIV counselling and testing (HCT) 
and increasing HIV prevention and harm 
reduction service coverage. As part of the 
evaluation for this project, we conducted a 
baseline assessment of HIV infection among 
male IDUs to understand the correlates of 
HIV infection and high risk injection practic-
es and sexual behaviour among male IDUs. 
Study Methodology 
The baseline assessment was undertaken 
from May to October 2011 at five sites within 
Delhi. The sites were operated by Sahara 
Centre for Residential Care and Rehabili-
tation. Participants were recruited through 
peer-referral, targeted outreach by outreach 
workers, and walk-ins. To be eligible, partic-
ipants had to be at least 18 years of age, 
residing in and around Delhi, and injected 
at least once in the last three months. 
Trained research interviewers administered 
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a close-ended questionnaire in Hindi to collect data on 
socio demographic characteristics, injecting practices, 
sexual behaviours, knowledge of HIV and utilization of 
harm reduction services. All participants were offered 
HIV testing based on three rapid tests per national HIV 
testing guidelines.
Study Population
A total of 3,792 males, including 10 transgenders, and 
26 females were recruited into the study. Overall, 53.6 
percent of the IDUs were recruited through targeted 
outreach, 26.3 percent through peer referral and 20.1 
percent were walk in clients. Due to the small num-
bers recruited, female IDUs were not included in the 
analysis. 
The median age was 30 years, 52.1 percent were 
never married, and 56.9 percent were less than 30 
years of age. About one-half (48.9 percent) were illit-
erate, 56.3 percent were daily wage earners, and 27.5 
percent were self-employed. IDUs were primarily either 
living in a family/relative’s home (43.1 percent) or in 
the street, slum or public area (40.3 percent). 
Key Findings
High acceptability of HIV testing  
among the IDUs
Almost all (95.4 percent) of male IDUs were 
tested; only 175 remained untested due to re-
fusal or blood draw not being possible. Only 37.6 
percent had previously been tested for HIV. Even 
more worrisome is that one-half (52.5 percent) 
of those who tested HIV positive in this study 
had never been tested before. 
High prevalence of HIV among the 
IDUs
HIV prevalence amongst those tested was 21.9 
percent. This is a much higher prevalence of HIV 
infection than the 10 percent reported by the 
sentinel surveillance conducted in Delhi in 2006 
and higher than the national HIV prevalence 
estimates (9.2 percent) for IDUs in 2010.8 The 
HIV prevalence of 21.9 percent is similar to the 
self-reported HIV prevalence we documented in 
our previous study among male IDUs in Delhi in 
2006.9
HIV-positive IDUs were more likely to report 
high risky injecting drugs behaviour com-
pared to HIV-negative IDUs
HIV-positive participants were more likely to have been 
using drugs (injecting and non-injecting) drugs for 
longer periods than HIV-negative IDUs; 53.3 percent 
HIV-positive IDUs were using drugs for more than 
11 years compared to 46.9 percent of HIV-negative 
participants (p < 0.001). HIV-positive male IDUs were 
also more likely to report unsafe injection practices 
in the last one month compared to HIV-negative male 
IDUs (Figure 1). HIV-positive IDUs were also more likely 
to access harm reduction services, particularly needle 
and syringe exchange program (NSEP) services (45.3 
percent vs. 30.1 percent; p < 0.001), compared to 
HIV-negative IDUs. 
Lower sexual activity reported by HIV-posi-
tive IDUs compared to HIV-negative IDUs
Overall sexual activity was low; 36.6 percent of par-
ticipants reported sexual intercourse in the last three 
months. HIV-positive IDUs were less sexually active, 
and reported unsafe sex with male and female part-
ners less frequently than HIV-negative IDUs (Figure 2). 
A fairly high proportion (15.3 percent) of HIV-positive 









































































HIV negative (n=2,817)HIV positive (n=795)
Figure 1  Injection behaviours of HIV-positive and HIV-negative  
                male IDUs in Delhi, 2011
*p < 0.001; **p < 0.01
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Injection drug use behaviours were the 
dominant risk factors for HIV infection com-
pared to sexual behaviours 
In multivariate analysis, after controlling for demo-
graphic variables, those who had been using drugs 
(non-injecting or injecting) longer, engaging in high-
risk injection practicesi, and having accessed harm 
reduction servicesii were more likely to be HIV infected. 
Alternatively, those who drank alcohol more frequent-
ly and engaged in unsafe sex with female partners 
(compared to those not having any sex with a female 
partner) were less likely to be HIV infected. 
Program Implications and  
Recommendations
The results of the baseline assessment as a part of 
the longitudinal study highlighted some key issues for 
HIV prevention program in Delhi. Inspite of a massive 
scale up of HIV counselling and testing services, the 
study reveals that less than 40 percent participants 
reported prior HIV testing despite having accessed 
iAn index was created for risky injection practices. The index includes 
(i) Using used needle or syringe; (ii) Back/front loaded/split drugs; (iii) 
Shared vial/cooker/container/cotton/filter/water; (iv) Received pre-filled 
injection; (v) Drew up drugs from common container.
iiHarm reduction services include NSEP services, abscess care, de-ad-
diction services and opioid substitution therapy.
other facilities such as abscess care and 
NSEP. Targeted intervention programs for 
IDUs require HIV testing for IDUs at six month 
intervals.10  Further, one-half of those who 
tested positive in this study had never been 
tested previously. Undiagnosed HIV infection 
impedes the prevention efforts and access 
to treatment and care for HIV-positive IDUs.  
It is imperative that prevention programmes 
emphasize and facilitate HIV testing in this 
population. 
We found that unsafe injection practices 
were reported more frequently by HIV-posi-
tive IDUs. Information, education and coun-
selling needs to be strengthened to empha-
size safer injecting practices. 
Table 1  Correlates of HIV-positive status among male 
               IDUs in Delhi, 2011
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Model is adjusted for age, education, marital status, religion, regional 
origin, accommodation, and income.
aIncludes: (i) Using used needle or syringe; (ii) Back/front loaded/split 
drugs; (iii) Shared vial/cooker/container/cotton/filter/water; (iv) Re-
ceived pre-filled injection; (v) Drew up drugs from common container.
bIncludes needle and syringe exchange program services, abscess care, 
de-addiction services and opioid substitution therapy.















































































Figure 2  Sexual behaviours in the last three months of  
                HIV-positive and HIV-negative male IDUs in Delhi, 2011
*p < 0.05; **p < 0.001
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Indeed, we found that HIV-positive IDUs were more 
likely to access NSEP services. Utilization of NSEP 
services does not necessarily translate into safe 
behaviours as HIV-positive IDUs were more likely to 
report unsafe injection practices. HIV-positive IDUs 
also reported more frequent injections and thus would 
require a larger supply of needles and syringes. It is 
possible that while HIV-positive IDUs were more likely 
to access NSEP services, it may not be possible for 
them to obtain a sufficient supply of clean needles. 
Programs need to ensure that HIV-positive IDUs are 
getting sufficient supply of sterile needles and syringes 
and that they are in fact using them. 
It is of concern that nearly one out of five HIV-posi-
tive IDUs reported unsafe sex with a regular female 
partner. The risk of onward HIV transmission to a sex 
partner remains high. Therefore, it is critical for HIV 
prevention programmes for IDUs to include their sex 
partners (regular and non regular partners). 
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